TITLE

Beyond The Stem Cell Debate

AUTHOR(S)
Netterwald, James
PUB. DATE
July 2009
SOURCE
Drug Discovery & Development;Jul2009, Vol. 12 Issue 7, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the expansion of human embryonic stem cells (hESC) lines and further use of induced pluripotent stem (iPS) cells as well as better tools for stem cell analysis which increase the success for stem cell-based therapies. It looks into the new guidelines released by the National Institutes of Health (NIH) for funding stem cell research involving embryonic stem cells. It also describes some research discoveries in global laboratories related to stem cell analysis. INSETS: Inking a Better Surface;hESC Guidelines Detail Funding Conditions.
ACCESSION #
43537512

Tags: EMBRYONIC stem cells;  CELL separation;  STEM cells -- Research;  CELLULAR therapy;  CYTOLOGY -- Technique;  NATIONAL Institutes of Health (U.S.)

 

Related Articles

  • Stem cell future in California.  // Reproductive BioMedicine Online;Jan2007, Vol. 14 Issue 1, p95 

    The article focuses on the 10-year plan of the California Stem-Cell Institute for stem cell technology. The plan's basic research is granted $823 million, preclinical research gets $899 million and training is given $295 million. The construction of the embryo stem laboratories are shouldered by...

  • Embryonic Stem Cell Research Moves Slowly Through Appeals Courts, Cancer Trials. Jenks, Susan // JNCI: Journal of the National Cancer Institute;Jul2011, Vol. 103 Issue 14, p1078 

    The article reports on the status of embryonic stem cell research in the U.S., noting the slow progress due to legal disputes which are affecting funding support. It cites the court case between the National Institutes of Health (NIH) and the two scientists James Sherley and Theresa Deisher on...

  • NIH releases guidelines for stem cell research.  // Issues in Science & Technology;Summer2009, Vol. 25 Issue 4, p20 

    No abstract available.

  • Stem cell research funding in jeopardy.  // Issues in Science & Technology;Winter2010, Vol. 27 Issue 2, p24 

    The article reports on the preliminary injunction issued by a federal judge that forbids the National Institutes of Health (NIH) to fund stem cell research in the U.S. District Court Judge Royce C. Lamberth said that under the Dickey-Wicker Amendment, human embryonic stem cell research is...

  • Federal Stem Cell Shift Seen Spurring Funding. Reed, Vita // Orange County Business Journal;3/23/2009, Vol. 32 Issue 12, p1 

    The article reports on the plan of stem cell researcher Hans Keirstead to apply for a challenge grant with the National Institutes of Health in Orange County, California. It is noted that the move of the administration of U.S. President Barack Obama to lift a ban on funding for research...

  • Amid legal uncertainties, NIH approves more embryonic stem cells. Dolgin, Elie // Nature Medicine;Jan2011, Vol. 17 Issue 1, p5 

    The article reports on the status of the legal battle of scientists regarding the legality of embryonic stem cell research in the U.S. It mentions that while the National Institutes of Health (NIH) awaits the decision of the federal district judge, it approved the addition of new cell lines. It...

  • ...and ES cell strategy. Ready, Tinker // Nature Medicine;May2001, Vol. 7 Issue 5, p518 

    Reports on the plan of the U.S. regarding research into embryonic stem cells (ES). Inability of the U.S. government to approve the legislation banning human cloning; Response of scientists to the guidelines prepared by National Institutes of Health; Establishment of a coalition for the support...

  • Bush compromise raises doubts over stem-cell resilience. Knight, Jonathan // Nature;8/16/2001, Vol. 412 Issue 6848, p665 

    Announces the approval by United States (U.S.) President George W. Bush of the government funding for human embryonic stem-cell research on August 9, 2001. Challenge facing U.S. stem-cell researchers; Number of stem cell lines that qualify for grants from the U.S. National Institutes of Health;...

  • NIH accused of being overly literal on stem cell approvals. Dolgin, Elie // Nature Medicine;Mar2012, Vol. 18 Issue 3, p325 

    The article reports on the interpretations of the U.S. National Institutes of Health (NIH) about the research proposal submitted by Andras Nagy, senior scientist at Mount Sinai Hospital, on human embryonic stem cells (ESCs). It is inferred that Nagy created CA1 and CA2, the first ESCs derived in...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics